Companies researching REGEN-COV
REGEN‑COV (casirivimab and imdevimab) is a monoclonal antibody therapy delivered via infusion or subcutaneous injection to treat and prevent COVID‑19.
0
companies
Frequently asked questions
REGEN‑COV (casirivimab and imdevimab) is a monoclonal antibody therapy delivered via infusion or subcutaneous injection to treat and prevent COVID‑19.
0
companies
Frequently asked questions